Related content

Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors

By  

The Oncologist, Vol. 23, Iss. 2, 2018-02 ,pp. : 155-e17

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prolonged Intermittent Oral Topotecan in Patients with Refractory and/or Advanced Malignancies: A Phase I Study

By Suzanne F. Jones  

American Journal of Cancer, Vol. 3, Iss. 5, 2004-01 ,pp. : 317-324

Adis International

Access to resources Recommend Favorite

Five days of oral topotecan (hycamtin ( R)), a phase I and pharmacological study in adult patients with solid tumours

By Gerrits C.J.H.   Burris H.   Schellens J.H.M.   Planting A.S.T.   van den Burg M.E.L.   Rodriguez G.I.   van Beurden V.   Loos W.J.   Hudson I.   Fields S.   Verweij J.   von Hoff D.D.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1030-1035

Elsevier

Access to resources Recommend Favorite

Phase I dose-finding study and a pharmacokinetic/pharmacodynamic analysis of the neutropenic response of intravenous diflomotecan in patients with advanced malignant tumours

By Trocòniz Iñaki   Garrido María   Segura Cristina   Cendrós Josep-María   Principe Paola   Peraire Concepción   Obach Rosendo  

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 727-735

Springer Publishing Company

Access to resources Recommend Favorite

Phase I pharmacokinetic and sequence finding study of the combination of docetaxel and methotrexate in patients with solid tumours

By Louwerens M.   Smorenburg C.   Sparreboom A.   Loos W.J.   Verweij J.   de Wit R.  

European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. : 497-504

Elsevier

Access to resources Recommend Favorite